Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Plasminogen Activator (PLAUR) ELISA Kit-Sandwich

Name: Canine Plasminogen Activator (PLAUR) ELISA Kit-Sandwich
SKU: EK10F918
Rating: 5 (1 reviews)

Cat. No.EK10F918

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Basket

Product Overview

BioVenic Canine PLAUR ELISA Kit-Sandwich is designed for the quantitative determination of Canine PLAUR in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine PLAUR.

Target Species Canine

Species Reactivity Canine

Detection Range 62.5-4000 pg/mL

Sensitivity 12.5 pg/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Plasminogen activator, urokinase receptor is encoded by the PLAUR gene in dogs. It plays a role in tumor progression and has been proposed as a target for the treatment of cancer.

Target/Biomarker Canine PLAUR

Target Synonym plasminogen activator; urokinase receptor; urokinase plasminogen activator surface receptor; urokinase plasminogen activator surface receptor

Gene ID 476446

UniProt ID A0A8P0SAA6

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Xu, X. et al. Identification of a new epitope in uPAR as a target for the cancer therapeutic monoclonal antibody ATN-658, a structural homolog of the uPAR binding integrin CD11b (αM). PloS one. 2014, 9: e85349.